[1]
Torre, L.A.; Bray, F.; Siegel, R.L.; Ferlay, J.; Lortet-Tieulent, J.; Jemal, A. Global cancer statistics, 2012. CA Cancer J. Clin., 2015, 65, 87-108.
[2]
McGuire, S. World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015. Adv. Nutr., 2016, 7, 418-419.
[3]
Nguyen, D.; Liao, W.; Zeng, S.X.; Lu, H. Reviving the guardian of the genome: Small molecule activators of p53. Pharmacol. Ther., 2017, 178, 92-108.
[4]
Worachartcheewan, A.; Mandi, P.; Prachayasittikul, V.; Toropova, A.P.; Toropov, A.A.; Nantasenamat, C. Large-scale QSAR study of aromatase inhibitors using SMILES-based descriptors. Chemom. Intell. Lab. Syst., 2014, 138, 120-126.
[5]
Villadsen, N.L.; Jacobsen, K.M.; Keiding, U.B.; Weibel, E.T.; Christiansen, B.; Vosegaard, T.; Bjerring, M.; Jensen, F.; Johannsen, M.; Torring, T.; Poulsen, T.B. Synthesis of ent-BE-43547A1 reveals a potent hypoxia-selective anticancer agent and uncovers the biosynthetic origin of the APD-CLD natural products. Nat. Chem., 2017, 9, 264-272.
[6]
Rayan, A.; Raiyn, J.; Falah, M. Nature is the best source of anticancer drugs: Indexing natural products for their anticancer bioactivity. PLoS One, 2017, 12, e0187925.
[7]
Bajaj, S.O.; Shi, P.; Beuning, P.J.; O'Doherty, G.A. Structure activity relationship study of Mezzettiasides natural products and their four new disaccharide analogues for anticancer/antibacterial activity. MedChemComm, 2014, 5, 1138-1142.
[8]
Sun, H.; Wang, Z.; Yakisich, J.S. Natural products targeting autophagy via the PI3K/Akt/mTOR pathway as anticancer agents. Anticancer. Agents Med. Chem., 2013, 13, 1048-1056.
[9]
Romero-Duran, F.J.; Alonso, N.; Yanez, M.; Caamano, O.; Garcia-Mera, X.; Gonzalez-Diaz, H. Brain-inspired cheminformatics of drug-target brain interactome, synthesis, and assay of TVP1022 derivatives. Neuropharmacology, 2016, 103, 270-278.
[10]
Tenorio-Borroto, E.; Penuelas-Rivas, C.G.; Vasquez-Chagoyan, J.C.; Castanedo, N.; Prado-Prado, F.J.; Garcia-Mera, X.; Gonzalez-Diaz, H. Model for high-throughput screening of drug immunotoxicity - Study of the anti-microbial G1 over peritoneal macrophages using flow cytometry. Eur. J. Med. Chem., 2014, 72, 206-220.
[11]
Speck-Planche, A.; Kleandrova, V.V.; Ruso, J.M.; Cordeiro, M.N.D.S. First multitarget chemo-bioinformatic model to enable the discovery of antibacterial peptides against multiple Gram-positive pathogens. J. Chem. Inf. Model., 2016, 56, 588-598.
[12]
Kleandrova, V.V.; Ruso, J.M.; Speck-Planche, A.; Dias Soeiro Cordeiro, M.N. Enabling the discovery and virtual screening of potent and safe antimicrobial peptides. Simultaneous prediction of antibacterial activity and cytotoxicity. ACS Comb. Sci., 2016, 18, 490-498.
[13]
Speck-Planche, A.; Cordeiro, M.N.D.S. Simultaneous virtual prediction of anti-Escherichia coli activities and ADMET profiles: A chemoinformatic complementary approach for high-throughput screening. ACS Comb. Sci., 2014, 16, 78-84.
[14]
Martinez-Arzate, S.G.; Tenorio-Borroto, E.; Barbabosa Pliego, A.; Diaz-Albiter, H.M.; Vazquez-Chagoyan, J.C.; Gonzalez-Diaz, H. PTML model for proteome mining of B-cell epitopes and theoretical-experimental study of Bm86 protein sequences from colima, Mexico. J. Proteome Res., 2017, 16, 4093-4103.
[15]
Casanola-Martin, G.M.; Le-Thi-Thu, H.; Perez-Gimenez, F.; Marrero-Ponce, Y.; Merino-Sanjuan, M.; Abad, C.; Gonzalez-Diaz, H. Multi-output model with Box-Jenkins operators of linear indices to predict multi-target inhibitors of ubiquitin-proteasome pathway. Mol. Divers., 2015, 19, 347-356.
[16]
Speck-Planche, A.; Cordeiro, M.N.D.S. Fragment-based in silico modeling of multi-target inhibitors against breast cancer-related proteins. Mol. Divers., 2017, 21, 511-523.
[17]
Gonzalez-Diaz, H.; Herrera-Ibata, D.M.; Duardo-Sanchez, A.; Munteanu, C.R.; Orbegozo-Medina, R.A.; Pazos, A. ANN multiscale model of anti-HIV drugs activity vs AIDS prevalence in the US at county level based on information indices of molecular graphs and social networks. J. Chem. Inf. Model., 2014, 54, 744-755.
[18]
Speck-Planche, A.; Dias Soeiro Cordeiro, M.N. Speeding up early drug discovery in antiviral research: A fragment-based in silico approach for the design of virtual anti-hepatitis C leads. ACS Comb. Sci., 2017, 19, 501-512.
[19]
Speck-Planche, A.; Cordeiro, M.N.D.S. De novo computational design of compounds virtually displaying potent antibacterial activity and desirable in vitro ADMET profiles. Med. Chem. Res., 2017, 26, 2345-2356.
[20]
Kleandrova, V.V.; Speck Planche, A. Multitasking model for computer-aided design and virtual screening of compounds with high anti-HIV activity
and desirable ADMET properties. In In: Multi-Scale Approaches in Drug Discovery: From Empirical Knowledge to In Silico Experiments and Back; 1st
ed.; Speck-Planche, A., Ed. Elsevier: Oxford, UK. , 2017; p. pp 55-81.
Related Journals
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current Bioactive Compounds
Current Cancer Drug Targets
Current Cancer Therapy Reviews
Current Drug Safety
Current Drug Targets
Recent Patents on Anti-Cancer Drug Discovery
Letters in Drug Design & Discovery
Current Drug Discovery Technologies
Current Radiopharmaceuticals
Related Books
Science of Spices and Culinary Herbs - Latest Laboratory, Pre-clinical, and Clinical Studies
Frontiers in Clinical Drug Research - Anti-Cancer Agents
Advances in Organic Synthesis
Frontiers in Natural Product Chemistry
Recent Advances in Analytical Techniques
Frontiers in Drug Design and Discovery
NEOPLASIA and FERTILITY
Therapeutic Use of Plant Secondary Metabolites
Frontiers in Computational Chemistry
Frontiers in Bioactive Compounds
Article Metrics
25
4